The Kamagra Paradox: Ajanta Sells FDA-Approved Sildenafil in America
The company behind Kamagra sells FDA-approved generic sildenafil in the United States — at 25, 50 and 100 mg, just never under the Kamagra name. What that paradox reveals about brand trust.
The fact almost nobody cites with receipts
Search the FDA’s National Drug Code directory for Ajanta Pharma USA Inc. and you find roughly 168 products — a full generics portfolio spanning cardiology, neurology, dermatology and more. Among them, listed plainly:
- Sildenafil Citrate 25 mg tablets — NDC 27241-067
- Sildenafil Citrate 50 mg tablets — NDC 27241-068
- Sildenafil Citrate 100 mg tablets — NDC 27241-069
- Sildenafil 20 mg tablets and a 10 mg/mL oral suspension (the pulmonary-hypertension strengths)
Every one carries ANDA status — an Abbreviated New Drug Application, the FDA’s approval pathway for generic medicines. That means FDA-reviewed bioequivalence data, FDA-inspected manufacturing, and batch-level accountability in the world’s most litigious pharmaceutical market.
So the question “is Kamagra made by a real pharmaceutical company?” has a documented answer: yes. Ajanta Pharma, founded in Mumbai in 1973, is an approved supplier to the US market for the exact molecule Kamagra is marketed around.
Then why is Kamagra itself unlicensed everywhere Western?
Because a company and a product are approved separately — and Ajanta never submitted Kamagra for approval in the UK, US, EU, Australia, or Singapore.
That is a commercial decision, not an oversight. In regulated markets, Ajanta competes the regulated way: plain generic sildenafil, prescription-only, distributed through licensed wholesalers and pharmacies. Kamagra — the branded tablets, the jelly, the chewables — is aimed at markets and channels where those approvals were never sought. When Kamagra appears in a Western country, it has arrived through channels no regulator supervises.
Why “the factory is legit” doesn’t authenticate your pack
This is the paradox worth understanding, because it cuts both ways:
- It undercuts the scare story. Kamagra is not the product of a mystery lab. Its maker passes FDA inspections.
- It undercuts the reassurance story too. The pack a third-party website ships you never passed through the supervised chain that FDA (or HSA, or MHRA) accountability depends on. Kamagra’s popularity makes it one of the most counterfeited ED brands — regulators repeatedly find lookalike products with wrong doses or different drugs entirely. A genuine factory 8,000 km away cannot vouch for the parcel at your door.
The UK’s MHRA has seized tens of millions of unlicensed erectile-dysfunction pills; Singapore’s HSA removes thousands of online listings a year and regularly finds adulterated sexual-enhancement products. None of that involves the FDA-approved bottles in American pharmacies — which is precisely the point. Same company, two supply chains, only one of them accountable.
The practical takeaway
If manufacturer legitimacy is what draws you to Kamagra, follow that logic to its conclusion: the most Ajanta-like product you can buy is registered generic sildenafil from a licensed pharmacy — in the US quite possibly made by Ajanta itself, and in Singapore an HSA-registered equivalent prescribed after a consultation. The brand name is the part that carries the risk, not the molecule and not the manufacturer.
Primary sources
- FDA National Drug Code directory: Ajanta Pharma USA sildenafil listings
NDC records for Ajanta's US sildenafil products; the FDA NDC database lists the 25/50/100 mg ANDA entries under labeler code 27241.
- Ajanta Pharma USA: official site
The company's US portfolio of FDA-approved generics.
- Ajanta Pharma: US generics business
Corporate description of the regulated US operation.
- MHRA: 20 million illegal erectile dysfunction pills seized
The unregulated-channel side of the paradox.
- HSA (Singapore): dangers of adulterated and counterfeit health products
Why unsupervised supply chains, not factories, are the risk.